Gengle Therapeutics Limited

Gengle Therapeutics Limited (Private company limited by shares) was originally incorporated on 2018-07-12 under the Companies Ordinance (Cap. 622) of Hong Kong. According to the official Government Gazette and Companies Registry records, the corporation was officially dissolved by notice published in the Government Gazette, currently holding the statutory legal status of [Dissolved], and its corporate legal personality has ceased (Statutory records last verified: March 2025).

The statutory primary identifiers for Gengle Therapeutics Limited are: 1. Business Registration Number (BRN / Unique Business Identifier UBI): [69625518] (effective from 27 December 2023, this 8-digit number issued under Cap. 310 serves as the unified cross-departmental corporate identifier); 2. Company Registration Number (CRN): [2721063] (incorporation archive number issued under Cap. 622). Together, these dual keys uniquely lock the entity in international banking KYC and cross-border contracts.

Although Gengle Therapeutics Limited has been dissolved, its historical corporate governance filings remain archived in the Hong Kong Companies Registry. Under the Companies Ordinance (Cap. 622), former directors, company secretaries, and historical shareholder equity distributions prior to dissolution can be verified by retrieving its historical Annual Returns (Form NAR1), Incorporation Form (Form NNC1), and Notices of Change of Company Secretary and Director (Form ND2A).

Yes. Statutory indexing confirms that Gengle Therapeutics Limited has accumulated 17 official filing dossier(s) archived in the Hong Kong Companies Registry (latest statutory filing indexed on 2025-03-07: Gazette Notice of Application for Deregistration (Cap. 622 s.751(1))). Pursuant to Section 662 of the Companies Ordinance (Cap. 622), private companies must deliver an Annual Return (Form NAR1) within 42 days after each incorporation anniversary. Available barcoded dossiers include: latest Annual Return (Form NAR1 - detailing current share capital, registered office, directors, and member shareholdings), Incorporation Form (Form NNC1), Articles of Association, and Change of Company Secretary and Director notices (Form ND2A), each bearing authentic ICRIS electronic barcode verification.

According to multi-dimensional checks across Hong Kong statutory authorities: 1. Regulatory Licences: No special statutory regulatory licence recorded, and the corporate entity has been officially dissolved; 2. Judicial Screening (Litigation & Winding-Up): cross-referenced with the Hong Kong Judiciary public writs database and Official Receiver's Office (ORO) registers; no public civil action writs (HCA/DCCJ) or compulsory winding-up petitions (HCCW under Cap. 32) were found on current index records.

According to statutory filings prior to dissolution, the last recorded statutory registered office of Gengle Therapeutics Limited was situated at: [Unit C, Block 4, 8/F, The Pinnacle, Tseung Kwan O, Hong Kong]. Official registry dossiers also record 3 statutory registered office address change filing(s) (Form NR1). Following its dissolution, the entity has ceased legal personality and statutory office maintenance obligations in Hong Kong.

No. Because Gengle Therapeutics Limited (CRN: 2721063 / 8-digit BRN: 69625518) has officially dissolved, its corporate legal personality and contractual capacity under the Companies Ordinance (Cap. 622) have ceased. Any external website, invoice, or commercial contract purporting to act on behalf of this dissolved company carries severe legal invalidity and impersonation risk. Historical verification of its pre-dissolution directors, Gazette dissolution notices, and statutory filings is established exclusively through certified records of the Hong Kong Companies Registry.